714208
L-醛赖氨酸乙烯乙缩醛
≥98% (TLC)
别名:
(S)-2-氨基-5-(1,3-二氧戊环-2-基)戊酸
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C8H15NO4
化学文摘社编号:
分子量:
189.21
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352209
MDL number:
产品名称
L-醛赖氨酸乙烯乙缩醛, ≥98% (TLC)
InChI
1S/C8H15NO4/c9-6(8(10)11)2-1-3-7-12-4-5-13-7/h6-7H,1-5,9H2,(H,10,11)/t6-/m0/s1
SMILES string
N[C@@H](CCCC1OCCO1)C(O)=O
InChI key
RQULWPSGQYZREI-LURJTMIESA-N
assay
≥98% (TLC)
form
crystals
optical activity
[α]/D +4.0±0.3°, c = 1 in H2O
reaction suitability
reaction type: solution phase peptide synthesis
application(s)
peptide synthesis
Quality Level
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Elizabeth Mary Mathew et al.
International journal of analytical chemistry, 2018, 2583215-2583215 (2018-08-30)
Pyridoxine dependent epilepsy is a condition where the affected infant or child has prolonged seizures (status epilepticus), which are nonresponsive to anticonvulsant therapy but can be treated with pharmacological doses of pyridoxine. If identified earlier and treated prophylactically with pyridoxine
Michael F Wempe et al.
Journal of inherited metabolic disease, 42(3), 565-574 (2019-01-22)
Pyridoxine-dependent epilepsy (PDE) is often characterized as an early onset epileptic encephalopathy with dramatic clinical improvement following pyridoxine supplementation. Unfortunately, not all patients present with classic neonatal seizures or respond to an initial pyridoxine trial, which can result in the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持